Aug 1, 2009 - The educational handout Continuous Glucose Monitoring was developed by the DCE ... to a wireless monitor.
Aug 1, 2009 - Jennifer Hyman, MS, RD, CDE, CDN. DCE Publications Committee Chair 2009-2010 ... Considerations for CGM. A
Continuous glucose monitoring pro- vides maximal information about shifting blood glucose levels throughout the day and facilitates the making of optimal ...
Nobue Tanaka, Junnosuke Miura, Izumi Fukuda, Masato Kanzaki, Tatsuo Sawada, ..... Hino N, Nakagawa Y, Ikushima Y, Yoshida M, Tsuyuguchi M. A case of a ...
Apr 25, 2018 - Keywords: continuous glucose monitoring; hypoglycaemia; ... (hypoglycaemia, postprandial hyperglycaemia) that may be at the root of acute ...
MiniMed Inc., Northridge, California. ..... nant patients show a lower correlation (0.84 vs. 0.90) and a .... Wentholt I.M.E., Hart A.A.M., Hoekstra J.B.L., DeVries J.H..
Aug 10, 2015 - Department of Pediatrics, Endocrinology, Diabetology with Cardiology Subdivision, Medical University of BiaÅystok,. Jana Kilinskiego 1, 15-089 ...
Oct 20, 2011 - Consensus Process: One group meeting, several conference calls, and e-mail communications enabled ... 1.1 We recommend against the use of RT-CGM alone for .... evidence, the reader should note that our implicit rec-.
From the 1Division of Diabetes and Nutritional Sciences, King's College London, London, U.K.; the 2De- partment of .... Jensen K, Kennedy-Martin T, Currie CJ.
Oct 29, 2013 - sensor warm up: 10 h; calibration at 10 h, 12 h, 24 h and 72 h. Advantages: ..... From the Internet blogs, it seems that the company went into ...
procijeni efikasnost metoda kontinuiranog supkutanog mjerenja glukoze u .... (categorical data) or means ± standard deviations (numeric data). Bivariate ...
scientific advisory boards from Bayer, Life Scan, Eli Lilly, sanofi-aventis, and Medtronic. Tadej Battelino is supported in part by the Slovenian. National Research ...
AUSTIN, G.E.; WHEATON, R; NANES, M.S.; RUBIN, J.; MULLINS, R.E. Usefulness of fructosamine for monitoring outpatients with. Diabetes. American Journal of ...
Background: Simultaneous pancreas-kidney (SPK) transplantation is an important replacement therapy for in- dividuals with diabetes and end-stage renal ...
Jul 30, 2013 - The median time to postprandial peak glucose levels(Peak Time) for each ... investigated postprandial glucose variations in type 2 diabetic.
Monitoring in Diabetic Patients ... thus constitutes a relatively easy method to monitor glucose excursions in diabetic ... through an infrared communicating port.
Mar 10, 2016 - Undergoing Extracorporeal Ventricular Assist. Therapy. Antje Gottschalk1⯠..... Moreover, especially when sickness is aggravated by liver dysfunction, the ..... learning algorithms to meet the challenges of an artificial pancreas.
Two main CGM brands have been used in neonates,. Medtronic Minimed ...... Kaiser JR, Bai S, Gibson N, Holland G, Lin TM, Swearingen CJ, et al. Association ...
Oct 29, 2013 - various non-invasive glucose monitoring techniques; alerts for hypo- and ..... The ongoing research efforts will provide the essential tools to.
monitoring system, (FD) finite differences, (FDA) Food and Drug Administration, (FIR) finite impulse response, (FSN-CGM) FreeStyle Navigator continuous ...
Jun 3, 2013 - Non-Invasive Continuous Glucose Monitoring with. Multi-Sensor Systems: A Monte Carlo-Based. Methodology for Assessing Calibration ...
Menarini Diagnostics) compared with venous blood glucose measurement in type 1 ... Percentage bias between the GlucoDay and the blood venous levels was ...
Mar 2, 2005 - The question of comparability between blood, central nervous system. (CNS) ... Knowledge concerning glucose measurements in subcu- taneous ... found to be delayed by 18 min compared with venous plasma, and in ... measured by a capillary
control group, blood glucose levels must be regulated by ... Comparison, and Outcome) model. .... group (venous blood glucose, capillary blood glucose or.
glycated hemoglobin (HbA1c) levels, with a mean change of â0.66%. The drug also ... tors improve mean blood glucose (MBG) level, postpran- dial hyperglycemia ... gone 1-week evaluation of blood glucose dynamics using a CGM system ( ...
Diabetology & Metabolic Syndrome
Torimoto et al. Diabetol Metab Syndr (2017) 9:60 DOI 10.1186/s13098-017-0258-5
Open Access
RESEARCH
Early effects of sodium‑glucose co‑transporter 2 inhibitors in type 2 diabetes: study based on continuous glucose monitoring Keiichi Torimoto, Yosuke Okada, Kenji Koikawa and Yoshiya Tanaka*
Abstract Background: Inhibitors of sodium-glucose co-transporter 2 (SGLT2) have immediate glucose-lowering effects by promoting urinary glucose excretion, without altering insulin level. Only a few studies have evaluated blood glucose dynamics in the early period after administration. The present retrospective study was designed to determine the immediate effects of SGLT2 inhibitors on blood glucose dynamics. Methods: The study subjects were 24 patients with type 2 diabetes whose blood glucose dynamics were evaluated with continuous glucose monitoring for 1 week before and after initiation of SGLT2 inhibitor therapy. Blood glucose dynamics were examined on days −1, 0 (treatment commencement day), 3, and 7 by evaluating different continuous glucose monitoring parameters and blood glucose before each meal. Furthermore, blood glucose levels at 1 and 2 h after each meal and daily urinary glucose levels were determined. Results: A significant reduction in blood glucose levels 2 h after breakfast was observed between the day before treatment (249.8 mg/dL) and the day treatment started (218.9 mg/dL). The mean daily blood glucose level improved significantly from 201.4 to 142.3 mg/dL from the day the treatment started. Blood glucose variation also improved significantly by week 1, as demonstrated by changes in standard deviation and mean amplitude of glycemic excursions (from 39.6 to 31.7 and 106.9 to 87.4 mg/dL, respectively). The percent time at blood glucose 20 years; (2) blood glucose level at admission
